Cargando…

Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients

BACKGROUND: Expression of long non-coding RNAs (lncRNAs) has recently been recognized as a potential prognostic marker in acute myeloid leukemia (AML). However, it remains unclear whether incorporation of the lncRNAs expression in the 2017 European LeukemiaNet (ELN) risk classification can further i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Cheng-Hong, Yao, Chi-Yuan, Tien, Feng-Min, Tang, Jih-Luh, Kuo, Yuan-Yeh, Chiu, Yu-Chiao, Lin, Chien-Chin, Tseng, Mei-Hsuan, Peng, Yen-Ling, Liu, Ming-Chih, Liu, Chia-Wen, Yao, Ming, Lin, Liang-In, Chou, Wen-Chien, Chen, Chien-Yu, Hou, Hsin-An, Tien, Hwei-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413345/ https://www.ncbi.nlm.nih.gov/pubmed/30662003 http://dx.doi.org/10.1016/j.ebiom.2019.01.022

Ejemplares similares

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
por: Hou, Hsin-An, et al.
Publicado: (2018)

Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis
por: Chen, Chien-Yuan, et al.
Publicado: (2013)

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
por: Tien, Feng-Ming, et al.
Publicado: (2018)

Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
por: Chen, Chien-Yuan, et al.
Publicado: (2018)

P721: VALIDATION OF THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES DEFINED BY INTERNATIONAL CONSENSUS CLASSIFICATION
por: Hsuan Lee, Wan, et al.
Publicado: (2023)

ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
por: Wang, Yu-Hung, et al.
Publicado: (2020)

High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia
por: Chen, Chien-Yuan, et al.
Publicado: (2015)

Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
por: Lin, Ming-En, et al.
Publicado: (2018)

Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
por: Tsai, Cheng-Hong, et al.
Publicado: (2017)

High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia
por: Lee, Sze-Hwei, et al.
Publicado: (2017)

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
por: Yao, Chi-Yuan, et al.
Publicado: (2016)

Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML
por: Tsai, Xavier Cheng-Hong, et al.
Publicado: (2023)

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
por: Hou, Hsin-An, et al.
Publicado: (2016)

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome
por: Yang, Yi-Tsung, et al.
Publicado: (2018)

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification
por: Lee, Wan-Hsuan, et al.
Publicado: (2023)

An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype
por: Chuang, Ming-Kai, et al.
Publicado: (2015)

Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
por: Huang, Shang-Yi, et al.
Publicado: (2014)

The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model
por: Hsu, Yueh-Chwen, et al.
Publicado: (2017)

Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
por: Huang, Huai-Hsuan, et al.
Publicado: (2019)

Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis
por: Lin, Shih-Chiang, et al.
Publicado: (2022)

A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes
por: Wang, Yu-Hung, et al.
Publicado: (2021)

Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
por: Cheng, Chieh-Lung, et al.
Publicado: (2015)

Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia
por: Chen, Chien-Yuan, et al.
Publicado: (2013)

Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
por: Wang, Yu-Hung, et al.
Publicado: (2020)

Clinical and Prognostic Implications of Roundabout 4 (Robo4) in Adult Patients with Acute Myeloid Leukemia
por: Chen, Yin-Kai, et al.
Publicado: (2015)

Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study
por: Huang, Shang-Yi, et al.
Publicado: (2015)

PD‐L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
por: Lee, Sze‐Hwei, et al.
Publicado: (2021)

Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients
por: Wang, Yu‐Hung, et al.
Publicado: (2022)

Intracranial hemorrhage in adult patients with hematological malignancies
por: Chen, Chien-Yuan, et al.
Publicado: (2012)

Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia
por: Lin, Chien-Chin, et al.
Publicado: (2017)

Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
por: Chiang, Yun, et al.
Publicado: (2016)

High BM plasma S100A8/A9 is associated with a perturbed microenvironmentand poor prognosis in myelodysplastic syndromes
por: Wang, Yu-Hung, et al.
Publicado: (2023)

Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
por: Ko, Bor-Sheng, et al.
Publicado: (2018)

Preoperative facet joint arthropathy does not impact long-term clinical outcomes after lumbar-stability-preserving decompression and dynesys fixation
por: Chou, Po-Hsin, et al.
Publicado: (2021)

Does local vancomycin powder impregnated with autogenous bone graft and bone substitute decrease the risk of deep surgical site infection in degenerative lumbar spine fusion surgery?—An ambispective study
por: Chou, Po-Hsin, et al.
Publicado: (2022)

Correction: Does local vancomycin powder impregnated with autogenous bone graft and bone substitute decrease the risk of deep surgical site infection in degenerative lumbar spine fusion surgery?—An ambispective study
por: Chou, Po‑Hsin, et al.
Publicado: (2023)

S171: HIGHER MDMX EXPRESSION WAS ASSOCIATED WITH HYPOMETHYLATING AGENT RESISTANCE AND WORSE SURVIVAL IN MYELODYSPLASTIC SYNDROME PATIENTS, INFERRING IT A POTENTIAL THERAPEUTIC TARGET
por: Wang, Yu-Hung, et al.
Publicado: (2023)

High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan
por: Tang, Jih-Luh, et al.
Publicado: (2015)

P720: A BONE MARROW MICROENVIRONMENTAL CELL SIGNATURE SCORING SYSTEM INDEPENDENTLY PREDICTED SURVIVAL AND DRUG RESISTANCE IN CHRONIC MYELOMONOCYTIC LEUKAEMIA PATIENTS
por: Wang, Yu-Hung, et al.
Publicado: (2023)

IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer
por: Chou, Chia-Hsuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q3vf2nkr11ga5nti9pp0v18f12